Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double Blind, Placebo Controlled, Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO6885247 Following 12 Weeks of Treatment in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH).
Conditions
Interventions
RO6885247
placebo
Locations
26
United States
Stanford, California, United States
Orlando, Florida, United States
Chicago, Illinois, United States
Boston, Massachusetts, United States
St Louis, Missouri, United States
New York, New York, United States
Start Date
November 1, 2014
Primary Completion Date
July 1, 2015
Completion Date
July 1, 2015
Last Updated
December 22, 2016
NCT05808764
NCT05861986
NCT05755451
NCT05618379
NCT02908685
NCT04674618
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions